Ovarian, Fallopian Tube, and Primary Peritoneal Cancer Screening (PDQ®)–Patient Version
Ovarian, fallopian tube, or primary peritoneal cancer screening has not been shown to reduce the chance of dying from these cancers. Not all screening tests are helpful, and many have risks. Learn more the potential benefits and harms of screening in this expert-reviewed summary.
Media Type: Html
- SourceUrl: https://www.cancer.gov/node/5060/syndication
- Syndication ID: 1572
- Language: English
- Source: National Cancer Institute (NCI)
- Date Syndication Captured: Saturday, September 14, 2013 at 09:02 AM
- Date Syndication Updated: Saturday, August 29, 2026 at 01:21 AM
Tags
General:
cancer
prevention
policy
screening
cessation
ovarian
patient
version
secondhand smoke
disease screening
fallopian tube cancer
ovarian epithelial cancer
primary peritoneal cavity cancer
Smoking Use and Tobacco Facts
Quitting Resources
Guidance, Regulations and Compliance
Embed Code Snippet
To get the embed code snippet please Login.
